Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-04-14 | Dr. Jeffrey Alan GravesPresident, CEO & Director | -30.50k | 60.39k | Sale to Issuer | 1.98 | 1.43M | -2.09% |
| 2026-04-14 | Ms. Phyllis B. NordstromExec. VP, CFO & Chief Administrative Officer | -1.63k | 3.22k | Sale to Issuer | 1.98 | 793.27k | -0.20% |
| 2026-04-14 | Mr. Reji PuthenveetilExec. VP of Additive Solutions & Chief Commercial Officer | -11.70k | 23.17k | Sale to Issuer | 1.98 | 502.13k | -2.28% |
| 2026-04-14 | Dr. Joseph ZuikerExec. VP of Engineering & Operations | -5.33k | 10.55k | Sale to Issuer | 1.98 | 278.05k | -1.88% |
| 2026-04-14 | Dr. Charles W. HullCo-Founder, Exec. VP, CTO of Regenerative Medicine & Director Emeritus | -4.10k | 8.12k | Sale to Issuer | 1.98 | 518.52k | -0.78% |
| 2026-04-01 | Dr. Charles W. HullCo-Founder, Exec. VP, CTO of Regenerative Medicine & Director Emeritus | -4.46k | 8.34k | Sale to Issuer | 1.87 | 522.62k | -0.85% |
| 2026-04-01 | Mr. Reji PuthenveetilExec. VP of Additive Solutions & Chief Commercial Officer | -17.70k | 33.10k | Sale to Issuer | 1.87 | 513.83k | -3.33% |
| 2026-04-01 | Dr. Joseph ZuikerExec. VP of Engineering & Operations | -8.32k | 15.56k | Sale to Issuer | 1.87 | 283.38k | -2.85% |
| 2026-04-01 | Ms. Phyllis B. NordstromExec. VP, CFO & Chief Administrative Officer | -14.52k | 27.15k | Sale to Issuer | 1.87 | 794.89k | -1.79% |
| 2026-04-01 | Dr. Jeffrey Alan GravesPresident, CEO & Director | -39.95k | 74.71k | Sale to Issuer | 1.87 | 1.46M | -2.66% |
| 2026-04-01 | Mr. Andrew William-Banasick WrightSenior VP of General Counsel & Corporate Secretary | -3.86k | 7.22k | Sale to Issuer | 1.87 | 142.78k | -2.63% |
| 2025-12-12 | Dr. Joseph ZuikerExec. VP of Engineering & Operations | -5.21k | 9.90k | Sale to Issuer | 1.90 | 199.20k | -2.55% |
| 2025-12-02 | Ms. Phyllis B. NordstromExec. VP, CFO & Chief Administrative Officer | -1.73k | 3.53k | Sale to Issuer | 2.04 | 634.41k | -0.27% |
| 2025-09-05 | Dr. Charles W. HullCo-Founder, Exec. VP, CTO of Regenerative Medicine & Director Emeritus | -4.93k | 10.45k | Sale to Issuer | 2.12 | 477.08k | -1.02% |
| 2025-09-05 | Mr. Andrew William-Banasick WrightSenior VP of General Counsel & Corporate Secretary | -5.86k | 12.41k | Sale to Issuer | 2.12 | - | - |
| 2025-09-05 | Dr. Joseph ZuikerExec. VP of Engineering & Operations | -6.73k | 14.27k | Sale to Issuer | 2.12 | 204.41k | -3.19% |
| 2025-09-05 | Ms. Phyllis B. NordstromExec. VP, CFO & Chief Administrative Officer | -13.39k | 28.38k | Sale to Issuer | 2.12 | 636.14k | -2.06% |
| 2025-09-05 | Mr. Reji PuthenveetilExec. VP of Additive Solutions & Chief Commercial Officer | -16.05k | 34.03k | Sale to Issuer | 2.12 | 431.53k | -3.59% |
| 2025-09-05 | Dr. Jeffrey Alan GravesPresident, CEO & Director | -40.13k | 85.07k | Sale to Issuer | 2.12 | 1.25M | -3.11% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
